Stay updated with breaking news from Clinical Updates. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
A platform designed to provide ambulatory surgery centers with infection prevention resources including access to third-party continuing education, timely industry news, clinical studies, and...
The oldest advice in the financial markets is to buy low and sell high. The trick to winning, however, is to find the right stocks to buy, and to remember that ‘buy low’ doesn’t always mean these stocks can’t go lower. Sometimes the best bargains really do come in at the lowest prices. There are plenty of stocks under $10 that won’t break your bank and still offer substantial upside potential. How substantial? Well, the analysts at investment banking giant Oppenheimer have pinpointed two winners
Planegg/Martinsried, June 14, 2023. Medigene AG (Medigene, FSE: MDG1, Prime Standard), an immuno-oncology platform company focusing on the discovery and development of T cell immunotherapies for solid tumors, will be
Item 8.01 Other Events Clinical Updates On April 23, 2023, IDEAYA Biosciences, Inc. announced interim results from its Phase 2 clinical trial evaluating darovasertib and crizotinib synthetic... | June 18, 2023
‘Misoprostol-only’ abortion with pills has proven safe and effective around the world, say Ipas clinical experts